Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| ITI Pharma and Healthcare Fund | Baroda BNP Paribas Business Conglomerates Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | ITI | Baroda BNP |
| NAV | ₹20.7004 | ₹10.3302 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 5.0 years | 1.2 years |
| Expense ratio | 0.9% | 1.6% |
| Stars | ★★★★★ | Not rated |
| Growth Score | 72.80 | — |
Returns
| ITI Pharma and Healthcare Fund | Baroda BNP Paribas Business Conglomerates Fund | |
|---|---|---|
| 1 month | +11.35% | +8.53% |
| 3 months | +4.42% | −0.90% |
| 6 months | +12.33% | +5.19% |
| YTD | +21.31% | −0.75% |
| 1 year | +18.01% | +0.16% |
| 3 years (CAGR) | +19.94% | — |
| 5 years (CAGR) | +15.73% | — |
| 10 years (CAGR) | — | — |
| Since launch | +15.56% | +2.72% |
Risk
| ITI Pharma and Healthcare Fund | Baroda BNP Paribas Business Conglomerates Fund | |
|---|---|---|
| Volatility | 15.9% | — |
| Downside volatility | 10.1% | — |
| Sharpe | 0.85 | — |
| Sortino | 1.34 | — |
| Calmar | 1.17 | — |
| Return / risk | 1.25 | — |
| Deepest fall | −17.69% | −14.70% |
| Days to recover | 364 | 128 |
| Below its high | +0.00% | −2.02% |
Against benchmark
| ITI Pharma and Healthcare Fund | Baroda BNP Paribas Business Conglomerates Fund | |
|---|---|---|
| Alpha | −1.30% | — |
| Beta | 0.98 | — |
| R² | 84.6% | — |
| Up capture | 94.1% | — |
| Down capture | 98.8% | — |
| Tracking error | 6.2% | — |
| Information ratio | −0.26 | — |
| Treynor | 0.13 | — |
Consistency
| ITI Pharma and Healthcare Fund | Baroda BNP Paribas Business Conglomerates Fund | |
|---|---|---|
| Best 1-year | +61.91% | +1.78% |
| Middle 1-year | +15.57% | −4.98% |
| Worst 1-year | −9.32% | −8.61% |
| 1-year periods with a loss | 21.7% | 78.9% |
| Middle 3-year | +21.36% | — |
| Positive months | 72.2% | — |
| Best day | +3.48% | +4.09% |
| Worst day | −3.28% | −3.36% |
| Worst 5% day | −1.48% | −1.67% |
| Positive days | 56.0% | 54.3% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| ITI Pharma and Healthcare Fund | Baroda BNP Paribas Business Conglomerates Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | +15.60% | — |
| 1-year XIRR | +27.81% | +5.77% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.